Identification of Key Elements in Prostate Cancer for Ontology Building via a Multidisciplinary Consensus Agreement

被引:0
|
作者
Moreno, Amy [1 ]
Solanki, Abhishek A. [2 ]
Xu, Tianlin [3 ]
Lin, Ruitao [3 ]
Palta, Jatinder [4 ]
Daugherty, Emily [5 ]
Hong, David [6 ]
Hong, Julian [7 ]
Kamran, Sophia C. [8 ]
Katsoulakis, Evangelia [9 ]
Brock, Kristy [10 ]
Feng, Mary [7 ]
Fuller, Clifton [1 ]
Mayo, Charles [11 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[2] Loyola Univ Med Ctr, Dept Radiat Oncol, Berwyn, IL 60402 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[4] Virginia Commonwealth Univ, Dept Med Phys, Richmond, VA 23284 USA
[5] Univ Cincinnati, Dept Radiat Oncol, Coll Med, Cincinnati, OH 45267 USA
[6] Univ Southern Calif, Dept Radiat Oncol, Los Angeles, CA 90089 USA
[7] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 93701 USA
[8] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02129 USA
[9] James A Haley VA Med Ctr, Dept Radiat Oncol, Tampa, FL 33612 USA
[10] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA
[11] Univ Michigan, Dept Radiat Phys, Ann Arbor, MI 48109 USA
关键词
prostate cancer; clinical guidelines; treatment-related toxicities; informatics; ontology; INTENSITY-MODULATED RADIOTHERAPY; PATIENT-REPORTED OUTCOMES; ACTIVE SURVEILLANCE; NON-INFERIORITY; RADIATION; MEN; DELPHI; TOXICITY; THERAPY; PHASE-3;
D O I
10.3390/cancers15123121
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Prostate cancer (PCa) is one of the most common cancers and the second leading cause of cancer-related deaths in men in the United States. Accurate diagnosis, management, and posttherapy surveillance are critical for optimizing survival and patient quality of life. Sharing information among providers is a challenge due to the use of different health information systems or data capture workflows which can lead to ambiguity and misinterpretation of shared information. The aim of our study was to formulate an expert panel-based consensus on PCa-specific key data elements. Using the Delphi method, PCa experts developed a two-tiered thirty-item list of treatment-related toxicities for standardized clinical data capture. Additionally, four multi-domain symptom questionnaires were ranked, and definitions on disease control metrics were formalized. These findings have been used to develop a comprehensive operational ontology for PCa care that can facilitate knowledge sharing and scalable machine learning approaches. Background: Clinical data collection related to prostate cancer (PCa) care is often unstructured or heterogeneous among providers, resulting in a high risk for ambiguity in its meaning when sharing or analyzing data. Ontologies, which are shareable formal (i.e., computable) representations of knowledge, can address these challenges by enabling machine-readable semantic interoperability. The purpose of this study was to identify PCa-specific key data elements (KDEs) for standardization in clinic and research. Methods: A modified Delphi method using iterative online surveys was performed to report a consensus agreement on KDEs by a multidisciplinary panel of 39 PCa specialists. Data elements were divided into three themes in PCa and included (1) treatment-related toxicities (TRT), (2) patient-reported outcome measures (PROM), and (3) disease control metrics (DCM). Results: The panel reached consensus on a thirty-item, two-tiered list of KDEs focusing mainly on urinary and rectal symptoms. The Expanded Prostate Cancer Index Composite (EPIC-26) questionnaire was considered most robust for PROM multi-domain monitoring, and granular KDEs were defined for DCM. Conclusions: This expert consensus on PCa-specific KDEs has served as a foundation for a professional society-endorsed, publicly available operational ontology developed by the American Association of Physicists in Medicine (AAPM) Big Data Sub Committee (BDSC).
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Monitoring Patients with Metastatic Hormone-Sensitive and Metastatic Castration-Resistant Prostate Cancer: A Multidisciplinary Consensus Document
    Lapini, Alberto
    Caffo, Orazio
    Pappagallo, Giovanni
    Iacovelli, Roberto
    D'Angelillo, Rolando Maria
    Vavassori, Vittorio
    Ceccarelli, Roberta
    Bracarda, Sergio
    Jereczek-Fossa, Barbara Alicja
    Da Pozzo, Luigi
    Conti, Giario Natale
    CANCERS, 2019, 11 (12)
  • [32] Multidisciplinary Consensus on the Prevention and Treatment of Osteoporosis and Fragility Fractures in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy
    Casado, Enrique
    Borque-Fernando, Angel
    Caamano, Manuel
    Grana, Jenaro
    Munoz-Rodriguez, Jesus
    Morote, Juan
    WORLD JOURNAL OF MENS HEALTH, 2022, 40 (01): : 74 - 86
  • [33] Computational Analysis of Differentially Expressed Circulating MicroRNA and Identification of Key Genes in Prostate Cancer
    Manoj, Anveshika
    Kumari, Shweta
    Prasad, Gautam
    Ahmad, Mohammad Kaleem
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2024,
  • [34] Identification of common key genes in breast, lung and prostate cancer and exploration of their heterogeneous expression
    Makhijani, Richa K.
    Raut, Shital A.
    Purohit, Hemant J.
    ONCOLOGY LETTERS, 2018, 15 (02) : 1680 - 1690
  • [35] Identification of key pathways and genes with aberrant methylation in prostate cancer using bioinformatics analysis
    Singh, Anshika N.
    Sharma, Neeti
    ONCOTARGETS AND THERAPY, 2017, 10 : 4925 - 4933
  • [36] Digital rectal examination in palpable rectal cancer: expert panel consensus on key elements and analysis of a case series
    Lee, J.
    Grubac, V.
    Baxter, N.
    Auer, R.
    Porter, G.
    Holm, T.
    Moran, B.
    Heald, R. J.
    Simunovic, M.
    BRITISH JOURNAL OF SURGERY, 2021, 108 (08) : E264 - E265
  • [37] Identification of hub genes in key hallmarks of ovarian cancer via bioinformatics analysis
    Su, Rongjia
    Jin, Chengjuan
    Jin, Chengwen
    Kuang, Menghua
    Xiang, Jiangdong
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (02) : 827 - +
  • [38] Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus
    Lebastchi, Amir H.
    George, Arvin K.
    Polascik, Thomas J.
    Coleman, Jonathan
    de la Rosette, Jean
    Turkbey, Baris
    Wood, Bradford J.
    Gorin, Michael A.
    Sidana, Abhinav
    Ghai, Sangeet
    Tay, Kae Jack
    Ward, John F.
    Sanchez-Salas, Rafael
    Muller, Berrend G.
    Malavaud, Bernard
    Mozer, Pierre
    Crouzet, Sebastien
    Choyke, Peter L.
    Ukimura, Osamu
    Rastinehad, Ardeshir R.
    Pinto, Peter A.
    EUROPEAN UROLOGY, 2020, 78 (03) : 371 - 378
  • [39] Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens
    Kench, James G.
    Clouston, David R.
    Delprado, Warick
    Eade, Thomas
    Ellis, David
    Horvath, Lisa G.
    Samaratunga, Hemamali
    Stahl, Jurgen
    Stapleton, Alan M. F.
    Egevad, Lars
    Srigley, John R.
    Delahunt, Brett
    PATHOLOGY, 2011, 43 (05) : 410 - 419
  • [40] Identification of open chromosomal regions and key genes in prostate cancer via integrated analysis of DNase-seq and RNA-seq data
    Wei, Xin
    Yu, Lili
    Jin, Xuefei
    Song, Lide
    Lv, Yanting
    Han, Yuping
    MOLECULAR MEDICINE REPORTS, 2018, 18 (02) : 2245 - 2252